AskNadia: I Need Free or Inexpensive Insulin

I receive many emails from people asking me to help them get access to insulin. This column is for you, the person and family member who has reached out to me for help in gaining access to free or affordable insulin. Dear PWD: Unfortunately, not everyone has access to good health insurance. For some, having a CGM or insulin pump may be like reaching for

Read more

AskNadia: Blue Cross Blue Shield Will Not Cover My Humalog Insulin

Dear Nadia, My Blue Cross Blue Shield health insurance company who charges me $1,235 a month, just informed me that they would no longer cover my Humalog insulin for my insulin pump in 2018. This news comes with a $565 increase in my monthly premium, starting in the new year. MS Dear MS: The pharmaceutical companies contract with the health insurance companies based on volume

Read more

BI-Lilly Alliance Creates Formidable Drug Development Combine

Pharma giants Boehringer Ingelheim (BI) and Eli Lilly and Company (Lilly) have formed the BI-Lilly Diabetes Alliance, a joint effort, involving the development of several drugs aimed at treating type 1 and type 2 diabetes patients. The Alliance recently showed up in force at the 74th American Diabetes Association Scientific Sessions in San Francisco, June 13-17. It made more than 40 presentations on drugs and

Read more

Lilly to Address Humulin R U-500 Insulin Errors

Insulin prescription errors rank first among all prescribed drugs. In an effort to remedy this problem, Eli Lilly is developing a prefilled pen for delivering Humulin R U-500 insulin as well as collaborating on the development of a dedicated U-500 syringe. This news comes from the Institute for Safe Medication Practices, which says that errors involving U-500 are a major cause for insulin’s number-one ranking among misprescribed drugs. The

Read more

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at the plant where it is manufactured are fixed. The delay does not call into question the safety or utility of the drug, which is manufactured by Eli Lilly and Boehringer Ingelheim. Empagliflozin is an SGLT-2 inhibitor that has already been shown in clinical trials to

Read more

Kris Freeman in Sochi: Type 1 Diabetes Skier- 4th Time Olympian

I remember first seeing Kris Freeman when he was 21 at a diabetes conference. Two years after he was diagnosed with type 1 diabetes, Eli Lilly began sponsoring his dream of becoming an Olympic cross-country skier. During his off-season, you can find Kris at diabetes camps inspiring children to follow their dream. He is the only person with diabetes to compete in a winter endurance

Read more

Promising New Type 2 Drug on Horizon

A new drug being developed by Eli Lilly Co. that duplicates the effects of a hormone may soon be added to the growing arsenal of pharmaceutical weapons available to treat type 2 diabetes. The injectable drug, called LY, is designed to mimic the effects of the hormone fibroblast growth factor 21 (FGF21), which is produced by the liver and helps regulate the metabolism of both

Read more

Lilly Launches Glucagon Mobile App

Lilly Diabetes recently launched the free Lilly Glucagon Mobile App to educate those who support people living with type 1 diabetes. The interactive app, available on the iTunes store for iPhone and iPad devices, provides caregivers, diabetes educators, and school nurses with visual and audio emergency instructions, as well as tools to track locations of glucagon kits and alerts for expiration dates. People with type

Read more